Banque Pictet & Cie’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-62,121	Closed	-$107K	–	409
2025 Q2	$107K	Sell	62,121 -4,173	-6%	-$10.4K	﹤0.01%	356
2025 Q1	$221K	Sell	66,294 -310,297	-82%	-$1.6M	﹤0.01%	376
2024 Q4	$2.79M	Buy	376,591 +54,832	+17%	+$508K	0.03%	198
2024 Q3	$3.02M	Sell	321,759 -346,891	-52%	-$3.29M	0.03%	171
2024 Q2	$5.36M	Sell	668,650 -20,706	-3%	-$222K	0.05%	144
2024 Q1	$10.2M	Sell	689,356 -88,682	-11%	-$1.03M	0.11%	89
2023 Q4	$6.33M	Buy	778,038 +144,244	+23%	+$755K	0.07%	138
2023 Q3	$2.88M	Buy	633,794 +99,636	+19%	+$651K	0.03%	179
2023 Q2	$3.76M	Sell	534,158 -138,730	-21%	-$993K	0.03%	182
2023 Q1	$4.11M	Buy	672,888 +106,316	+19%	+$734K	0.04%	192
2022 Q4	$3.62M	Sell	566,572 -29,040	-5%	-$227K	0.04%	211
2022 Q3	$5.71M	Sell	595,612 -88,721	-13%	-$1.02M	0.06%	163
2022 Q2	$7.55K	Buy	684,333 +148,563	+28%	+$1.95M	0.07%	122
2022 Q1	$8.92M	Buy	535,770 +1,734	+0.3%	+$26.8K	0.07%	130
2021 Q4	$10.2M	Buy	534,036 +467,364	+701%	+$10.3M	0.08%	130
2021 Q3	$1.64M	Buy	66,672 +7,552	+13%	+$178K	0.02%	216
2021 Q2	$1.54M	Buy	59,120 +41,523	+236%	+$1.08M	0.02%	222
2021 Q1	$557K	Buy	+17,597	New	+$729K	0.01%	288